-+ 0.00%
-+ 0.00%
-+ 0.00%

Kyntra Bio says FibroGen Europe unit settles bankruptcy obligations for about $0.1 million

PUBT·08/31/2026 21:19:12
Listen to the news
Kyntra Bio says FibroGen Europe unit settles bankruptcy obligations for about $0.1 million
  • Kyntra Bio’s FibroGen Europe unit settled bankruptcy-related product development obligations and accrued interest for about USD 0.1 million.
  • The liabilities totaled USD 19.2 million at filing, driving a non-operating gain in Q2 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kyntra Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-377059), on August 31, 2026, and is solely responsible for the information contained therein.